Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05838482
Other study ID # 23000861577
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 7, 2023
Est. completion date May 2025

Study information

Verified date June 2024
Source GE Healthcare
Contact Melissa Challman
Phone +1-858-221-3007
Email melissa.challman@gehealthcare.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of the study is to collect data to evaluate utility of the using photon-counting CT in a clinical setting.


Description:

Data collected in this study includes an assessment of image quality parameters including spatial resolution, image contrast, and noise that will evaluate the product and how this photon-counting CT technology can be used to reduce the overall radiation dose in CT imaging, and enhance clinical applications for CT technology. This data and analysis will help support regulatory submission.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 2025
Est. primary completion date May 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Who are 18 years of age or older - Able to sign and date the informed consent form - Who have in the past 120 days or will in the future 30 days undergo a clinically-indicated CT exam of the head, neck, heart, chest, abdomen, pelvis, or extremities where images are available for this prior scheduled exam Exclusion Criteria: - Who are pregnant or lactating; - Who were previously enrolled in this study; - For contrast-enhanced CT exams, anyone with known or suspected allergy to iodinated contrast agents - For contrast-enhanced CT exams, anyone with known or suspected renal insufficiency as determined by site medical personnel; - Who need urgent or emergent care; - Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the subject; OR - Who are unwilling to have GEHC personnel present for the CT exam.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
CT Photon-Counting
Enrolled subjects will complete an exam using the photon-counting CT, with or without IV contract as indicated. Images will then be compared with the previously acquired CT conducted as standard of care.

Locations

Country Name City State
United States Stanford University Palo Alto California

Sponsors (2)

Lead Sponsor Collaborator
GE Healthcare Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Data Collection Number of Participants with raw investigational photon-counting CT scan data along with prior standard of care diagnostic CT exam data/images 1 year
Secondary Image Quality Reconstructed images produced from the raw investigational photon-counting CT scan will be scored for image quality using a Likert Scale (1 - Non-Diagnostic to 5 - Excellent Image Quality) 1 year
See also
  Status Clinical Trial Phase
Completed NCT04781296 - Spectral CT With Advanced CT Technology N/A